首页> 外文期刊>Clinical ophthalmology >Intrastromal Corneal Ring Segments Implantation And Corneal Cross-Linking For Keratoconus In Children With Vernal Keratoconjunctivitis – Three-Year Results
【24h】

Intrastromal Corneal Ring Segments Implantation And Corneal Cross-Linking For Keratoconus In Children With Vernal Keratoconjunctivitis – Three-Year Results

机译:春季角振炎儿童Keratoconus的科内角膜环段植入和角膜交联 - 三年效果

获取原文
           

摘要

Purpose: To assess the 3-year safety and efficacy of femtosecond laser-assisted intrastromal corneal ring segments’ (ICRS) implantation followed or accompanied by transepithelial accelerated corneal collagen cross-linking (TE-ACXL) as a treatment of keratoconus in children with vernal keratoconjunctivitis (VKC). Patients and methods: Fifty two eyes of 28 children with keratoconus and vernal VKC were included in this study. Cases were divided into 2 groups; the first group had been treated with femtosecond laser-assisted ICRS (Keraring) implantation accompanied or followed by TE-ACXL, while the second group had been treated by TE-ACXL only and all cases completed a follow-up period of 3 years. Results: In group 1: the mean uncorrected (UCVA) and best-corrected (BCVA) visual acuity, spherical equivalent, K-max and Q-value improved markedly from 0.97 ± 0.19, 0.67 ± 0.18, ?8.75 ± 4.55, 60.41 ± 4.98, and ?1.18 ± 0.54 preoperatively to 0.61 ± 0.27, 0.39±0.21, ?3.25 ± 3.56, 55.22 ± 5.72, and ?0.44 ± 0.68 postoperatively respectively. While in group 2: the preoperative mean UCVA, BCVA, spherical equivalent, K-max and Q-values were 0.68 ± 0.28, 0.38 ± 0.24, ?2.84 ± 2.59, 50.29 ± 4.04, and-0.58 ± 0.23 respectively while their corresponding postoperative values were 0.58 ± 0.34, 0.19 ± 0.17, ?2.35 ± 2.07, 49.58 ± 3.26, and ?0.57 ± 0.25. Only one case in group 1 required repeat cross-linking. Conclusion: Although the long-term safety and efficacy of femtosecond laser-assisted ICRS implantation accompanied or followed by TE-ACXL in children with keratoconus and VKC is high, some cases still may need repeat cross-linking.
机译:目的:评估飞秒激光辅助科技角膜环段'(ICRS)植入的3年安全性和功效,伴随着Transepithelial加速角膜胶原蛋白交联(TE-ACX1)作为春季儿童的角蛋白酶的治疗角膜炎(VKC)。患者和方法:本研究纳入了28名患有角蛋白和春季VKC的儿童的五十两只眼睛。病例分为2组;第一个组已被Femtosecond激光辅助的ICRS(Keraring)植入治疗,伴随或后面是TE-ACXL,而第二组织仅由TE-ACXL治疗,所有案例完成3年的后续期间。结果:在第1组:平均未校正(UCVA)和最佳校正(BCVA)视力,球形等效物,K-MAX和Q值显着改善0.97±0.19,0.67±0.18,α.8.75±4.55,60.41± 4.98,术前至0.61±0.27,0.39±0.21,α.3.25±3.56,55.22±5.72,分别术后为0.39±0.21,0.44±0.68。在第2组中:术前平均UCVA,BCVA,球面等效物,K-MAX和Q值分别为0.68±0.28,0.38±0.24,?2.84±2.59,50.29±4.04和-0.58±0.23,而其相应的术后术后值为0.58±0.34,0.19±0.17,?2.35±2.07,49.58±3.26和?0.57±0.25。第1组中只有一个案例需要重复交联。结论:虽然小飞秒激光辅助ICRS植入的长期安全性和疗效伴随或随后在KeratoConus和VKC儿童中携带的Te-ACXL很高,但有些情况仍可能需要重复交联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号